Abstract
Sensitive and specific radioimmunoassays for both sultopride and sulpiride were developed. Using these radioimmunoassays, the regional distributions of sultopride and sulpiride in rat brain after intraperitoneal administration were investigated. Although relatively small amounts of both drugs were detected in the brain, sultopride appears to pass the blood-brain barrier more easily than sulpiride. Relatively high concentrations of sultopride were seen in hypothalamus, striatum, the mesolimbic area and hippocampus, while sulpiride accumulated mainly in brain areas such as hypothalamus, medulla oblongata and cerebellum, where the blood-brain barrier is less effective. Both drugs seem to be concentrated by the pituitary and pineal body. These differences between sultopride and sulpiride in penetration to the brain may depend on their different lipid solubilities, since sultopride has a higher lipid solubility compared with sulpiride.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alam AS, Imondi AR, Udinsky J, Hagerman LM (1979) Bioavailability of [14C]sulpiride in dogs. Arch Int Pharmacodyn Ther 242:4–13
Costall B, Funderburk WH, Leonard CA, Nayler RJ (1978) Assessment of the neuroleptic potential of some novel benzamides, butyrophenone, phenothiazine and indole derivatives. J Pharm Pharmacol 30:771–778
Debeljuk L, Rozados R, Daskal H, Velez CV, Mancini AM (1975) Acute and chronic effects of sulpiride on serum prolactin and gonadotropin levels in castrated male rats. Proc Soc Exp Biol Med 148:550–552
Dross K, Hopf A (1979) Studies on the distribution of [14C]sulpiride and its metabolites in the rat and guinea pig. Pharmakopsychiatr Neuropsychopharmakol 12:438–444
Elliott PNC, Jenner P, Huizing G, Marsden CD, Miller R (1977) Substituted benzamides as cerebral dopamine antagonists in rodents. Neuropharmacology 16:333–342
Elliott PNC, Jenner P, Marsden CD (1978) Atropin manipulation of elevated cerebral dopamine turnover caused by haloperidol or substituted benzamide drugs. J Pharm Pharmacol 30:788–791
Glasson B, Benakis A, Khandjian A (1972) Metabolism du sulpiride [14C]. IX Congr Internat de Gastroenterologie, Paris, p 89
Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. 1. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 13:655–669
Guilmot P, Van Schepdael T (1976) La place du sultopride en thérapeutique psychiatrique. Sem Hop Paris 52:35–40
L'Hermite M, MacLeod RM, Robyn C (1978) Effects of two substituted benzamides, tiapride and sultopride, on gonadotrophins and prolactin. Acta Endocrinol 89:29–37
Hopf A, Dross K (1978) Comparative studies on the metabolism and the distribution of sulpiride and sultopride. II Congreso Mundial de Psychiatria Biologica Barcelona
Horn AS, Cuello AC, Miller RJ (1974) Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity. J Neurochem 22:265–270
Jenner P, Elliott PNC, Clow A, Reavill C, Marsden CD (1978) A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs. J Pharm Pharmacol 30:46–48
Jenner P, Marsden CD (1979) The mechanisms of action of substituted benzamide drugs. In: Spano PF, Trabucchi M, Corsini GU, Gessa GL (eds) Sulpiride and other benzamides. Raven Press, New York, pp 119–147
Lewi PJ, Heykants JJP, Allewijn FTN, Dony JGH, Janssen PAJ (1970) Distribution and metabolism of neuroleptic drugs. Arzneim-Forsch 20:943–948
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Mizuchi A, Saruta S, Kitagawa N, Miyachi Y (1981) Development of radioimmunoassay for sultopride and sulpiride. Arch Int Pharmacodyn Ther 254:317–326
Mizuchi A, Kitagawa N, Saruta S, Miyachi Y (1982) Characteristics of [3H]sultopride binding to rat brain. Eur J Pharmacol 84:51–59
Mouren P, Majet L, Larrien A (1970) Essai clinique d'une molecule nouvelle: le sulpiride, en pratique psychiatrique. Sem Hop Paris 46:97–100
Öhman R, Larsson M, Nilsson IM, Engel J, Carlsson A (1977) Neurometabolic and behavioral effects of haloperidol in relation to drug levels in serum and brain. Naunyn-Schmiedeberg's Arch Pharmacol 299:105–114
Puech AJ, Simon P, Boissier JR (1978) Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects. Eur J Pharmacol 50:291–300
Rodbard D, Rayford RL, Cooper JA (1968) Statistical quality control of radioimmunoassay. J Clin Endocrinol Metab 28:1412–1418
Stefanini E, Marchisio AM, Devoto P, Venaleone F, Collu R, Spano PF (1980) Sodium-dependent interaction of benzamides with dopamine receptors. Brain Res 198:229–233
Theodorou AE, Hall MD, Jenner P, Marsden CD (1980) Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to striatal preparations. J Pharm Pharmacol 32:441–444
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mizuchi, A., Kitagawa, N. & Miyachi, Y. Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay. Psychopharmacology 81, 195–198 (1983). https://doi.org/10.1007/BF00427261
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427261